Investors
Investors
Corporate Profile
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its two Pernix sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, L.L.C. and Cypress Pharmaceuticals, Inc.
Investor Events
Q2 2018 Pernix Therapeutics Holdings Inc Earnings Conference Call
Thursday, August 9, 2018 4:30 p.m. ET
View more
Q1 2018 Pernix Therapeutics Holdings, Inc. Earnings Conference Call
Thursday, May 10, 2018 4:30 p.m. ET
View more
Events & Presentations